Cambridge Healthtech Institute is pleased to announce the Fifth Annual ADAPT 2013: Accelerating Development & Advancing Personalized Therapy Congress is moving to Boston! ADAPT Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making ADAPT Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers.
This year, the coverage has been expanded to eight meetings, focusing on:
Companion diagnostics, including strategies for drug-diagnostics co-development on a global scale; and technology platforms and assay development for CDx
Biomarkers, including strategies to accelerate and de-risk drug development through clinical and translational biomarkers; and the clinical utility of biomarkers for patient stratification
Cancer, including the latest research on the role of exosomes/microvesicles and tumor microenvironment in cancer mechanism, and their impact on cancer drug and diagnostic development
Genomic medicine, including the latest advances and challenges in personalized medicine implementation; and the clinical utility of next-generation sequencing.
If you are interested in presenting, please click here to submit your proposal.
Deadline for submission is Friday, May 3, 2013